Compare RANI & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | SCOR |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 112.4M |
| IPO Year | 2021 | 2007 |
| Metric | RANI | SCOR |
|---|---|---|
| Price | $0.96 | $8.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 13.8K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.14 | ★ 127.37 |
| EPS | N/A | ★ 4.25 |
| Revenue | $1,633,000.00 | ★ $403,549,000.00 |
| Revenue This Year | $274.77 | $2.75 |
| Revenue Next Year | $79.44 | $7.30 |
| P/E Ratio | ★ N/A | $1.91 |
| Revenue Growth | ★ 58.85 | 1.02 |
| 52 Week Low | $0.39 | $4.39 |
| 52 Week High | $3.87 | $10.18 |
| Indicator | RANI | SCOR |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 68.97 |
| Support Level | $0.45 | $6.22 |
| Resistance Level | $1.22 | $9.34 |
| Average True Range (ATR) | 0.09 | 0.50 |
| MACD | 0.03 | 0.15 |
| Stochastic Oscillator | 94.39 | 97.45 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.